Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT OPERATING AND NONOPERATING ITEMS (Details)

v2.4.0.6
SIGNIFICANT OPERATING AND NONOPERATING ITEMS (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Available-for-Sale Securities
Dec. 31, 2010
Available-for-Sale Securities
Dec. 31, 2009
Bottlers Franchise rights [Member]
Dec. 31, 2009
Buildings and improvements.
Dec. 31, 2011
Merger of Embotelladoras Arca SAB de CV and Grupo Continental SAB [Member]
Dec. 31, 2010
Coca-Cola Enterprises Inc.
Dec. 31, 2011
Japans events [Member]
Dec. 31, 2011
Deductions from Revenue
Japans events [Member]
Dec. 31, 2011
Cost of Sales [Member]
Japans events [Member]
Dec. 31, 2011
Other operating charges [Member]
Japans events [Member]
Dec. 31, 2011
Corporate
Dec. 31, 2010
Corporate
Dec. 31, 2009
Corporate
Dec. 31, 2011
Corporate
Available-for-Sale Securities
Dec. 31, 2011
Corporate
Merger of Embotelladoras Arca SAB de CV and Grupo Continental SAB [Member]
Dec. 31, 2010
Corporate
Coca-Cola Enterprises Inc.
Dec. 31, 2011
Corporate
Coca-Cola Embonor SA [Member]
Dec. 31, 2010
Corporate
Leao Junior SA [Member]
Dec. 31, 2011
Corporate
Disposal of Norwegian and Swedish Bottling Operations [Member]
Dec. 31, 2010
Corporate
Disposal of Norwegian and Swedish Bottling Operations [Member]
Dec. 31, 2011
Corporate
Thailand events [Member]
Dec. 31, 2010
Acquisition of Coca Cola Enterprises North American Business [Member]
Dec. 31, 2011
Acquisition of Coca Cola Enterprises North American Business [Member]
Dec. 31, 2011
Acquisition of Coca Cola Enterprises North American Business [Member]
Disposal of Norwegian and Swedish Bottling Operations [Member]
Apr. 02, 2010
Venezuelan subsidiary
Dec. 31, 2010
Venezuelan subsidiary
Corporate
Significant Operating and Nonoperating Line Items                                                          
Unusual or Infrequent Event Charges                   $ 84 $ 23 $ 11 $ 50                     $ 10          
Other Operating Charges                                                          
Other operating charges 732 819 313                     164 485 129                          
Productivity, integration and restructuring initiatives 633 478 273                                                    
Charitable contributions   250                                                      
Transactions costs incurred in connection with CCE's acquisition                                                 81   84    
Charges related to bottling activities in Eurasia   10                                                      
Asset Impairment Charges Operating     40     23 17     1                                      
Equity Income (Loss) - Net                                                          
Our proportionate share of unusual or infrequent items recorded by our equity method investees 53 66 86                         2                          
Other Income (Loss) - Net                                                          
Gain related to remeasurement of our equity investment in CCE to fair value 0 4,978             4,978                   4,978                    
Gain (Loss) on the sale of Norwegian and Swedish bottling operations to New CCE                                           (5) 597            
Gain on sale of investment in subsidiary                                         23                
Percentage of Sale of Investments in Subsidiary                                         50.00%                
Percentage of the carrying value of investment (as a percent)                                         50.00%                
Remaining ownership percent (as a percent)                                         50.00%                
Charge related to preexisting relationships                                     265           265 1      
Initial remeasurement of net assets in a hyperinflationary economy                                                       103 103
Other-than-temporary impairment charges on available-for-sale securities, equity method investments and donations of preferred shares   48                         25                            
Other-than-temporary impairment charges, available-for-sale securities 17 26   (17) (26)                       17                        
Gain on sale of securities 5   44                         44                          
Cost method investments, other-than-temporary decline in fair value     27                         27                          
Net Gain On Exchange Of Equity Securities                                   417                      
Net Gains From Investee Transactions, equity investment sales and other equity investments transactions and Equity Investment Sales 122 0                       122                              
Equity Method Investment, Realized Gain (Loss) on Disposal                                       102                  
Equity Method Investments Impairment                           41                              
Costs related to exchange of equity securities of an investee               $ 35